Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment
- PMID: 940594
- DOI: 10.1007/BF00498583
Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment
Abstract
The endogenous levels of dopamine (DA) in the rat heart and submaxillary gland after a single, large dose of reserpine (10 mg/kg i.p.) were reduced to near zero within 1 h and were restored to normal within 48 h, while the noradrenaline (NA) levels reacted much more slowly. The data suggest that newly formed DA is rapidly taken up by the reserpinesensitive mechanism of the amine storage granules. The more rapid restoration of DA than of NA levels may be due to preferential release of newly formed NA by the nerve impulse. Electrical stimulation of the cervical sympathetic with 5 Hz for 30 min 4 h after the administration of reserpine increased the DA level of the submaxillary gland of the stimulated side, suggesting an increased tyrosine hydroxylase activity during stimulation, also in nerve terminals affected by reserpine. The use of an inhibitor of monoamine oxidase (pargyline) and/or an inhibitor of dopamine beta-hydroxylase (FLA-63) did not significantly alter the increase of DA following nerve stimulation, suggesting DA was protected by granular uptake. The stimulation-induced increase in DA was, however, much less in reserpine-treated than in normal animals, demonstrating the importance of the reserpine-sensitive uptake mechanisms for preserving newly formed DA.
Similar articles
-
A comparison of rates of depletion and recovery of noradrenaline stores of peripheral and central noradrenergic neurones after reserpine administration: importance of neuronal activity.Br J Pharmacol. 1980 Jan;68(1):93-8. doi: 10.1111/j.1476-5381.1980.tb10703.x. Br J Pharmacol. 1980. PMID: 7357203 Free PMC article.
-
The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat.Naunyn Schmiedebergs Arch Pharmacol. 1973;278(1):1-12. doi: 10.1007/BF00501858. Naunyn Schmiedebergs Arch Pharmacol. 1973. PMID: 4145469 No abstract available.
-
Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.J Pharmacol Exp Ther. 1986 Apr;237(1):179-92. J Pharmacol Exp Ther. 1986. PMID: 3007736
-
Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.Pharmacol Rev. 1972 Jun;24(2):203-21. Pharmacol Rev. 1972. PMID: 4405385 Review. No abstract available.
-
Noradrenergic influences on dopaminergic function and the pharmacology of dihydroxyphenylserine (DOPS): implication for Parkinson's disease.Clin Neuropharmacol. 1985;8(3):249-59. doi: 10.1097/00002826-198509000-00005. Clin Neuropharmacol. 1985. PMID: 3930069 Review. No abstract available.
Cited by
-
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulation.Naunyn Schmiedebergs Arch Pharmacol. 1977 Mar;297(1):17-22. doi: 10.1007/BF00508805. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 870830